AgomAb Therapeutics NV (AGMB)
Nasdaq: AGMB · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2024
The company now
AgomAb Therapeutics NV is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836). Its filings are on EDGAR under CIK 2020932; the figures the desk reads are not on file yet.
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.